Xtx Topco LTD Dexcom Inc Transaction History

Xtx Topco LTD

$1.13 Billion
Q4 2024

A detailed history of Xtx Topco LTD transactions in Dexcom Inc stock. As of the latest transaction made, Xtx Topco LTD holds 10,016 shares of DXCM stock, worth $664,361. This represents 0.07% of its overall portfolio holdings.

Number of Shares

10,016

Previous 29,104 65.59%

Holding current value

$664,361

Previous $1.95 Million 60.1%

% of portfolio

0.07%

Previous 0.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$65.68 - $81.01 $1.25 Million - $1.55 Million	-19,088 Reduced 65.59%	10,016 $778,000
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $1.86 Million - $3.38 Million	29,104 New	29,104 $1.95 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $508,621 - $623,865	4,453 New	4,453 $617,000
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $160,415 - $257,101	1,864 Added 40.67%	6,447 $601,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $173,653 - $202,233	-1,544 Reduced 25.2%	4,583 $588,000
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $289,952 - $342,700	-2,788 Reduced 31.27%	6,127 $711,000
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $288,677 - $416,709	-3,397 Reduced 27.59%	8,915 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $377,779 - $466,002	4,948 Added 67.19%	12,312 $992,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $354,295 - $692,489	5,211 Added 242.03%	7,364 $549,000
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $162,193 - $224,464	1,724 Added 401.86%	2,153 $1.1 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $55,714 - $69,849	429 New	429 $230,000
Q2 2021 Aug 12, 2021	SELL	$80.99 - $107.93 $161,170 - $214,780	-1,990 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $168,732 - $208,432	1,990 New	1,990 $715,000

Others Institutions Holding DXCM

# of Institutions

1,088

Shares Held

353M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account